San Antonio Breast Cancer Symposium (SABCS 2024)

Dr. Denis Landaverde (Costa Rica) - NATALEE 4 años: supervivencia libre de enfermedades a distancia

 

Distant disease-free survival (DDFS) across key subgroups from the phase 3 NATALEE trial of ribociclib (RIB) plus a nonsteroidal aromatase inhibitor (NSAI) in patients with HR+/HER2- early breast cancer (EBC)

FA-11324976